You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from Med-X.

Disrupting the Future of Pest Control

Thousands of investors are backing Med-X ahead of its planned Nasdaq listing (ticker: MXRX).

The company's momentum is undeniable – and the next stage of growth could belong to early shareholders.

For decades, chemical giants have dominated pest control. But the world is changing fast. Governments are banning toxic formulations, consumers demand transparency, and entire industries are being forced to evolve.

Med-X is leading that transition with Nature-Cide, its line of professional-grade, plant-based pesticides designed to perform better – without the health or environmental risks.

In independent lab studies, Nature-Cide's natural formulations have beaten chemical brands head-to-head, proving that "green" can also mean "powerful."

As the biopesticide market surges 3x by 2030, Med-X is positioned to disrupt a $17 billion industry with U.S.-made, scalable technology that's already trusted worldwide.

NASDAQ Ticker: MXRX Reserved!
Buy Now at $4 Per Share

Be Part of the Clean Pest Control Revolution.

With $6.4 M in sales, online retail placement through Amazon, Walmart, and Kroger, and expansion into 41 international markets, Med-X is scaling a proven model right as the world shifts toward sustainable agriculture and eco-friendly pest management.

Simpler. Safer. More Effective Pesticides.

Become a Med-X shareholder at $4 per share before the Nasdaq plans unfold.

Disclosures

This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com

We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security.

We would like to inform you that this is a paid advertisement for Med-X's Regulation A+ Offering offering and we have received or expect to receive compensation in connection with the disbursing this communication for Med-X . The compensation could consists of $1,000 or more and was received/will be received from Investing Media Solutions.

This communication should not be considered as an endorsement of Med-X and we are not responsible for any errors or omissions in any information provided about by or about Med-X.

We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions.

This disclosure is made as of 12/16/2025.

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431

Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.

Behind the Markets

You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here.

Today's Bonus Content: 5 Stocks That Could Double Your Investment in 2026

(By clicking this link you agree to receive emails from Trading Tips and our affiliates. You can opt out at any time. - Privacy Policy)